Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
Boost Invest MedVallée: a decisive springboard for Montpellier’s global healthcare startups
Photobiomodulation: light to treat Alzheimer’s disease
REGEnLIFE cures inflammatory brain diseases with light

The Microbiome at the Heart of Tomorrow’s Therapies – Narbonne | 16 & 17 April 2026

Participation in the event ‘The Microbiome in Occitanie: An Ecosystem in Action – The Microbiome at the Heart of Tomorrow’s Therapies’ – 16 and 17 April in Narbonne.

Pitch and poster presentation on ‘Non-invasive neuro-intestinal modulation in Alzheimer’s disease’

Our Light4Life clinical trial, currently underway in six hospitals – including three in Occitanie, such as Toulouse University Hospital – involves 108 patients and involves the collection of several biobanked biological samples: blood, saliva and faeces, to analyse the gut microbiota…

Speakers: Cédric Bertrand, Guillaume Blivet, Julien Delrieu, Jacques Touchon

Microbiome_occitanie_2026_
Share this article